The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein
Top Cited Papers
- 1 November 2005
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 8 (5), 355-368
- https://doi.org/10.1016/j.ccr.2005.10.015
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Dose-dependent effects of Bcr-Abl in cell line models of different stages of chronic myeloid leukemiaOncogene, 2005
- The biology of CML blast crisisBlood, 2004
- Protein Phosphatase 2A Dephosphorylation of Phosphoserine 112 Plays the Gatekeeper Role for BAD-Mediated ApoptosisMolecular and Cellular Biology, 2003
- Active Localization of the Retinoblastoma Protein in Chromatin and Its Response to S Phase DNA DamageMolecular Cell, 2003
- Reduction of Ha-ras-induced cellular transformation by elevated expression of protein phosphatase type 2AMolecular Carcinogenesis, 1999
- The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cellsOncogene, 1997
- Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantationBlood, 1993
- Regulation of Protein Serine-Threonine Phosphatase Type-2A by Tyrosine PhosphorylationScience, 1992
- Effector function for RAS oncogene in interleukin-3-dependent myeloid cells involves diminished efficacy of prostaglandin E1-mediated inhibition of proliferationBlood, 1989
- Forskolin: A potential antimetastatic agentInternational Journal of Cancer, 1983